Bhas Dani

Bhas Dani has extensive experience in the biopharmaceutical industry. Bhas is currently serving as the Vice President of Biologics CMC Development & Manufacturing at Exelixis. Prior to this, they held the position of Chief Technical Officer at Soteria Biotherapeutics, where they led Technical Operations and various other functions involved in the development of bispecific antibodies and small molecule drugs.

Bhas also worked at AbbVie as the Executive Director of Biologics Product Development, where they oversaw the product development of biologics and provided strategic leadership to ensure optimal manufacturing. Before that, they held the role of Director of Pharmaceutical Development and Technical Project Leader at Novartis, where they led the development of antibody drug conjugates and served as a Technical Project Leader for biologics. Earlier in their career, they worked as a Scientist in formulation development at Chiron Corporation and Nektar Therapeutics.

Bhas Dani holds a Ph.D. in Pharmaceutical Sciences from the University of Kentucky. Bhas also has a Master of Science (M.S.) in Pharmaceutical Sciences from Auburn University.